Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
71 /100
HIGH RISK
Score updated Oct 13, 2026

INAB — IN8bio, Inc. Dilution Risk Tracker

Track INAB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track INAB — Get alerts when the score changes →

As of October 13, 2026, IN8bio, Inc. (INAB) has a DilutionWatch DilutionScore of 71/100, rated HIGH dilution risk. IN8bio, Inc. has a market capitalization of $12.13M, 9.86M shares outstanding, 20 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
65
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 26%
🔄 Reverse Split model est. 40%
• 50-day avg $1.54 approaching $1 threshold
• 9 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (71/100)
🔔 Track INAB — Get forecast alerts →

Market Data

Market Cap$12.13M
Shares Outstanding9.86M
Float7.03M
Cash$18.13M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore71/100DilutionWatch score record
Shares Outstanding9.86MVerified float table or market cache
Public Float7.03MVerified float table or market cache
Market Cap$12.13MMarket data cache
Cash Runway9.3 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 15.3% shares (2026Q1 vs prior)
20 institutional holders · 3.75M shares
#1 Alyeska Investment Group, L.P. 944.3K shares
#2 FRANKLIN RESOURCES INC 914.5K shares
#3 683 Capital Management, LLC 724.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest46.4K
Days to Cover1.0
% of Float0.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2024-03-14
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual INAB Dilution Snapshot

IN8bio, Inc. (INAB) has a DilutionScore of 71/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

INAB's DilutionScore is currently 71/100 (High risk), with 1 score change tracked over 89 days. The score improved from 67/100 (High risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202671/100HIGH60 days
Jul 16 – Aug 13, 202667/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

INAB shares outstanding have decreased 0.0% from 9.77M (Mar 2026) to 9.77M (Mar 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Mar 17, 20269.77M7.03M▲ 0.33%
Mar 16, 20269.77M7.01M▲ 112.48%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track INAB Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment INAB files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking INAB — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for INAB
INAB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.